Paul, Weiss is advising Amedisys on the deal.Amedisys (NASDAQ: AMED) and Optum have agreed to combine. The agreement calls for the acquisition of Amedisys’s outstanding common…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
